Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ·Healthcare·Biotechnology
$104.88
+0.31%
Mkt Cap $6.96B
Analyst Ratings
Buy
19
Hold
0
Sell
0
Price Target (49 analysts)
$146.00
Range $118.00 – $185.00
Implied Upside
+39.2%
Consensus $146.00 vs current $104.88